You are here

  • Home
  • Archive
  • Volume 33, Issue Suppl 4
  • PR013/#1503  Toripalimab combined with bevacizumab and chemotherapy as first-line treatment for refractory, recurrent or metastatic cervical cancer: a single-arm, open-label, phase II TRIA

Alerts

Article menu

Download PDFPDF

Featured Posters: Poster Rounds with the Professors
AS03. Cervical cancer
PR013/#1503  Toripalimab combined with bevacizumab and chemotherapy as first-line treatment for refractory, recurrent or metastatic cervical cancer: a single-arm, open-label, phase II TRIA
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address